BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30061721)

  • 1. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America.
    Cano L; Cerapio JP; Ruiz E; Marchio A; Turlin B; Casavilca S; Taxa L; Marti G; Deharo E; Pineau P; Bertani S
    Sci Rep; 2018 Jul; 8(1):9945. PubMed ID: 30061721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.
    Osawa M; Akuta N; Suzuki F; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Suzuki Y; Ikeda K; Kumada H
    J Med Virol; 2017 Dec; 89(12):2144-2148. PubMed ID: 28667756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden.
    Marchio A; Cerapio JP; Ruiz E; Cano L; Casavilca S; Terris B; Deharo E; Dejean A; Bertani S; Pineau P
    Sci Rep; 2018 Aug; 8(1):12031. PubMed ID: 30104677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
    Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
    J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
    Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
    Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
    Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan.
    Lee CM; Chen CH; Lu SN; Tung HD; Chou WJ; Wang JH; Chen TM; Hung CH; Huang CC; Chen WJ
    Scand J Gastroenterol; 2003 Jan; 38(1):95-101. PubMed ID: 12608471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
    Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
    Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
    Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
    Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
    Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.